This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AIG To Sell Alico to MetLife for $15.5B

Updated from 1:17 a.m. EST

NEW YORK ( TheStreet) -- AIG (AIG - Get Report) reached an agreement to sell its foreign life insurance unit, American Life Insurance, to MetLife (MET - Get Report).

The unit is being sold to MetLife for about $15.5 billion, including $6.8 billion in cash and $8.7 billion in equity securities of MetLife.

AIG said the cash portion of the proceeds from this sale will be used to reduce the preferred shares in Alico held by the Federal Reserve Bank of New York.

Separately, MetLife said the equity portion of the purchase price will consist of 78.2 million MetLife common shares valued at $3.0 billion, 6.9 million shares of contingent convertible preferred stock valued at $2.7 billion and 40 million equity units having a value of $3 billion.

MetLife said it expects the cash portion of the purchase price to be financed through issuing senior debt and common stock as well as cash on hand.

The insurer said it expects the transaction to boost its 2011 operating earnings by 45 cents to 55 cents a share, and enable MetLife to increase its estimated 2011 year-end operating return on equity by 140 to 160 basis points.

The deal for Alico comes just a week after AIG agreed to sell its Asian life insurance unit to the U.K.'s Prudential (PUK) for $35.5 billion.

Shares of AIG closed Friday up $1.37 at $28.08. Shares of MetLife ended the session up 81 cents at $38.92.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AIG $61.58 -0.81%
MET $55.72 -0.78%
AAPL $125.58 -0.68%
FB $87.13 -0.18%
GOOG $522.26 -0.22%

Markets

DOW 17,628.09 -102.02 -0.58%
S&P 500 2,063.25 -13.53 -0.65%
NASDAQ 4,974.2270 -34.9870 -0.70%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs